Nephros

Nephros Net Tangible Assets

The Net Tangible Assets of Nephros (NEPH) as of Nov 9, 2026 is 9.44 M USD. In the previous year, Net Tangible Assets was 7.26 M USD — a change of 30.05% (higher).

Net Tangible Assets

9.44 MUSD

YoY

30.05%

Last updated:

Net Tangible Assets of Nephros is 2025 9.44 M USD. Net Tangible Assets of Nephros was 2024 7.26 M USD. It decreases by 30.05% higher compared to the previous year.

The Nephros Net Tangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Tangible Assets
Date
Net Tangible Assets
Jan 1, 2018
1.52 M USD
Jan 1, 2019
2.57 M USD
Jan 1, 2020
10.58 M USD
Jan 1, 2021
8.87 M USD
Jan 1, 2022
4.00 M USD
Jan 1, 2023
6.95 M USD
Jan 1, 2024
7.26 M USD
Jan 1, 2025
9.44 M USD
The Nephros Net Tangible Assets history
YEARNet Tangible AssetsYoY
9.44 MUSD+30.05%
7.26 MUSD+4.52%
6.95 MUSD+73.54%
4.00 MUSD-54.85%
8.87 MUSD-16.22%
10.58 MUSD+312.43%
2.57 MUSD+68.82%
1.52 MUSD+72.73%
880,000.00USD-248.40%
-593,000.00USD-122.26%
2.66 MUSD-146.89%
-5.68 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Nephros Stock analysis

What does Nephros do? Nephros, Inc. generates revenue through its Water Filtration and Renal Products segments. The Water Filtration segment sells high-performance water purification filters for hospitals, healthcare facilities, dialysis centers, commercial facilities, military, and outdoor recreation markets. The Renal Products segment offers a second-generation hemodiafiltration system for end-stage renal disease patients. Products include ultrafiltration systems used in medical and commercial applications, with subsidiaries Biocon 1, LLC, Aether Water Systems, LLC, and Specialty Renal Products, Inc. supporting sales and development. The company's water filtration products are sold to hospitals, dialysis centers, and commercial facilities, while the hemodiafiltration system targets healthcare providers treating ESRD patients. Subsidiaries handle specialized development and distribution, ensuring market coverage across medical and commercial sectors. Revenue streams are derived from both segments, with products serving healthcare infrastructure and renal treatment needs. Nephros, Inc. focuses on medical device solutions for renal disease and water purification, leveraging its subsidiaries to expand market reach. The Water Filtration segment serves healthcare and commercial clients, while the Renal Products segment addresses ESRD treatment through advanced hemodiafiltration technology, creating a diversified revenue model. Nephros is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Nephros stock

Net Tangible Assets of Nephros is 9.44 M USD in 2025.

Net Tangible Assets of Nephros changed from 7.26 M USD to 9.44 M USD, representing a 30.05% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Tangible Assets Nephros since 2006 – with annual values, charts, and detailed analysis.

Net tangible assets equal total assets minus intangible assets, goodwill, and liabilities. They represent the physical asset backing of a company.

Net Tangible Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Tangible Assets's Nephros historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Nephros

All Key Metrics — Nephros